Y-Intercept (HK)’s Bausch Health BHC Stock Holding History

Y-Intercept (HK)’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$459K	Sell	93,069 -11,356	-11%	-$60.9K	0.01%	1337
2026 Q1	$564K	Sell	104,425 -107,806	-51%	-$645K	0.01%	1232
2025 Q4	$1.48M	Buy	212,231 +145,671	+219%	+$958K	0.03%	779
2025 Q3	$429K	Buy	66,560 +41,799	+169%	+$286K	0.01%	1302
2025 Q2	$165K	Buy	+24,761	New	+$127K	﹤0.01%	1488
2024 Q2	–	Sell	-105,765	Closed	-$1.12M	–	1402
2024 Q1	$1.12M	Sell	105,765 -40,435	-28%	-$354K	0.08%	343
2023 Q4	$1.17M	Buy	+146,200	New	+$1.06M	0.11%	266
2022 Q3	–	Sell	-48,992	Closed	-$410K	–	963
2022 Q2	$410K	Buy	+48,992	New	+$685K	0.05%	482
2021 Q2	–	Sell	-12,499	Closed	-$490K	–	626
2021 Q1	$490K	Buy	+12,499	New	+$367K	0.13%	261

Other funds holding BHC

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Y-Intercept (HK)'s BHC Position: Q2 2026 in Review

Y-Intercept (HK) reduced its Bausch Health (BHC) stake by 11% in Q2 2026, selling an estimated $60.9K and leaving 93,069 shares worth $459K. The position accounts for 0.01% of the portfolio, ranked #1337.

Y-Intercept (HK) first reported a position in BHC in Q1 2021 and has held it in 9 quarters since. The position peaked at $1.48M in Q4 2025. 222 funds tracked by Wall St. Rank hold BHC as of Q2 2026.

Y-Intercept (HK) held 93,069 shares of Bausch Health worth $459K as of Q2 2026.
Y-Intercept (HK) sold 11,356 Bausch Health shares in Q2 2026, an estimated $60.9K.
Bausch Health made up 0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1337 holding.
Y-Intercept (HK) first reported a position in Bausch Health in Q1 2021 and has held it in 9 quarters since.
Y-Intercept (HK)'s Bausch Health position peaked at $1.48M in Q4 2025.
222 funds tracked by Wall St. Rank held Bausch Health as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.